Tenax Therapeutics, Inc.
TENX
$5.80
$0.030.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.27M | -3.96M | -3.58M | -3.80M | -3.23M |
| Total Depreciation and Amortization | -- | -- | -- | -- | 5.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 969.10K | 20.90K | 31.30K | 126.80K | 39.90K |
| Change in Net Operating Assets | 1.77M | 852.30K | 513.30K | -1.49M | 2.01M |
| Cash from Operations | -3.53M | -3.09M | -3.03M | -5.17M | -1.18M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 200.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 200.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -100.00 | -278.80K | -134.40K | -87.70K | -174.20K |
| Issuance of Common Stock | -- | 91.95M | 0.00 | 8.35M | -- |
| Repurchase of Common Stock | -100.24M | -- | -- | -- | -14.19M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.30M | 340.60K | 0.00 | -340.60K | 14.19M |
| Cash from Financing | 67.20K | 92.01M | -134.40K | 7.92M | -174.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.46M | 88.93M | -3.17M | 2.76M | -1.35M |